Medical Care
Global Drug of Abuse (DOA) Testing Market Research Report 2024
- Jan 20, 24
- ID: 15392
- Pages: 75
- Figures: 141
- Views: 36
The drug of abuse test is an immunoassay based on the principle of competitive binding.
The global Drug of Abuse (DOA) Testing market was valued at US$ 6321 million in 2023 and is anticipated to reach US$ 9703.7 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
North America will dominate the drug of abuse testing market in 2022 owing to high R&D investment, presence of global players, increasing adoption of technologically advanced solutions, and efforts of major companies. In North America, the U.S. accounted for the major share accounting for 90% owing to the rise in the use of illicit drugs and the resulting increase in health problems. Rising monitoring of illicit drug consumption in the workplace and rise in drug trafficking are other factors contributing to the market growth.
This report aims to provide a comprehensive presentation of the global market for Drug of Abuse (DOA) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug of Abuse (DOA) Testing.
Report Scope
The Drug of Abuse (DOA) Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug of Abuse (DOA) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug of Abuse (DOA) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Siemens
Merck
Roche
Thermo Fisher Scientific
Bio-Rad
Abbott
Quest Diagnostics
Psychemedics
Segment by Type
Urine
Saliva
Hair
Others
Segment by Application
Hospitals
Laboratories
Workplace
At-Home
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug of Abuse (DOA) Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Drug of Abuse (DOA) Testing market was valued at US$ 6321 million in 2023 and is anticipated to reach US$ 9703.7 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
North America will dominate the drug of abuse testing market in 2022 owing to high R&D investment, presence of global players, increasing adoption of technologically advanced solutions, and efforts of major companies. In North America, the U.S. accounted for the major share accounting for 90% owing to the rise in the use of illicit drugs and the resulting increase in health problems. Rising monitoring of illicit drug consumption in the workplace and rise in drug trafficking are other factors contributing to the market growth.
This report aims to provide a comprehensive presentation of the global market for Drug of Abuse (DOA) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug of Abuse (DOA) Testing.
Report Scope
The Drug of Abuse (DOA) Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug of Abuse (DOA) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug of Abuse (DOA) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Siemens
Merck
Roche
Thermo Fisher Scientific
Bio-Rad
Abbott
Quest Diagnostics
Psychemedics
Segment by Type
Urine
Saliva
Hair
Others
Segment by Application
Hospitals
Laboratories
Workplace
At-Home
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug of Abuse (DOA) Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug of Abuse (DOA) Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Urine
1.2.3 Saliva
1.2.4 Hair
1.2.5 Others
1.3 Market by Application
1.3.1 Global Drug of Abuse (DOA) Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Workplace
1.3.5 At-Home
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug of Abuse (DOA) Testing Market Perspective (2019-2030)
2.2 Drug of Abuse (DOA) Testing Growth Trends by Region
2.2.1 Global Drug of Abuse (DOA) Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug of Abuse (DOA) Testing Historic Market Size by Region (2019-2024)
2.2.3 Drug of Abuse (DOA) Testing Forecasted Market Size by Region (2025-2030)
2.3 Drug of Abuse (DOA) Testing Market Dynamics
2.3.1 Drug of Abuse (DOA) Testing Industry Trends
2.3.2 Drug of Abuse (DOA) Testing Market Drivers
2.3.3 Drug of Abuse (DOA) Testing Market Challenges
2.3.4 Drug of Abuse (DOA) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug of Abuse (DOA) Testing Players by Revenue
3.1.1 Global Top Drug of Abuse (DOA) Testing Players by Revenue (2019-2024)
3.1.2 Global Drug of Abuse (DOA) Testing Revenue Market Share by Players (2019-2024)
3.2 Global Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug of Abuse (DOA) Testing Revenue
3.4 Global Drug of Abuse (DOA) Testing Market Concentration Ratio
3.4.1 Global Drug of Abuse (DOA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug of Abuse (DOA) Testing Revenue in 2023
3.5 Drug of Abuse (DOA) Testing Key Players Head office and Area Served
3.6 Key Players Drug of Abuse (DOA) Testing Product Solution and Service
3.7 Date of Enter into Drug of Abuse (DOA) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug of Abuse (DOA) Testing Breakdown Data by Type
4.1 Global Drug of Abuse (DOA) Testing Historic Market Size by Type (2019-2024)
4.2 Global Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2025-2030)
5 Drug of Abuse (DOA) Testing Breakdown Data by Application
5.1 Global Drug of Abuse (DOA) Testing Historic Market Size by Application (2019-2024)
5.2 Global Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug of Abuse (DOA) Testing Market Size (2019-2030)
6.2 North America Drug of Abuse (DOA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug of Abuse (DOA) Testing Market Size by Country (2019-2024)
6.4 North America Drug of Abuse (DOA) Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug of Abuse (DOA) Testing Market Size (2019-2030)
7.2 Europe Drug of Abuse (DOA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug of Abuse (DOA) Testing Market Size by Country (2019-2024)
7.4 Europe Drug of Abuse (DOA) Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug of Abuse (DOA) Testing Market Size (2019-2030)
8.2 Asia-Pacific Drug of Abuse (DOA) Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug of Abuse (DOA) Testing Market Size (2019-2030)
9.2 Latin America Drug of Abuse (DOA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug of Abuse (DOA) Testing Market Size by Country (2019-2024)
9.4 Latin America Drug of Abuse (DOA) Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug of Abuse (DOA) Testing Market Size (2019-2030)
10.2 Middle East & Africa Drug of Abuse (DOA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Siemens
11.1.1 Siemens Company Detail
11.1.2 Siemens Business Overview
11.1.3 Siemens Drug of Abuse (DOA) Testing Introduction
11.1.4 Siemens Revenue in Drug of Abuse (DOA) Testing Business (2019-2024)
11.1.5 Siemens Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Drug of Abuse (DOA) Testing Introduction
11.2.4 Merck Revenue in Drug of Abuse (DOA) Testing Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Drug of Abuse (DOA) Testing Introduction
11.3.4 Roche Revenue in Drug of Abuse (DOA) Testing Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Drug of Abuse (DOA) Testing Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Bio-Rad
11.5.1 Bio-Rad Company Detail
11.5.2 Bio-Rad Business Overview
11.5.3 Bio-Rad Drug of Abuse (DOA) Testing Introduction
11.5.4 Bio-Rad Revenue in Drug of Abuse (DOA) Testing Business (2019-2024)
11.5.5 Bio-Rad Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott Drug of Abuse (DOA) Testing Introduction
11.6.4 Abbott Revenue in Drug of Abuse (DOA) Testing Business (2019-2024)
11.6.5 Abbott Recent Development
11.7 Quest Diagnostics
11.7.1 Quest Diagnostics Company Detail
11.7.2 Quest Diagnostics Business Overview
11.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Introduction
11.7.4 Quest Diagnostics Revenue in Drug of Abuse (DOA) Testing Business (2019-2024)
11.7.5 Quest Diagnostics Recent Development
11.8 Psychemedics
11.8.1 Psychemedics Company Detail
11.8.2 Psychemedics Business Overview
11.8.3 Psychemedics Drug of Abuse (DOA) Testing Introduction
11.8.4 Psychemedics Revenue in Drug of Abuse (DOA) Testing Business (2019-2024)
11.8.5 Psychemedics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug of Abuse (DOA) Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Urine
1.2.3 Saliva
1.2.4 Hair
1.2.5 Others
1.3 Market by Application
1.3.1 Global Drug of Abuse (DOA) Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Workplace
1.3.5 At-Home
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug of Abuse (DOA) Testing Market Perspective (2019-2030)
2.2 Drug of Abuse (DOA) Testing Growth Trends by Region
2.2.1 Global Drug of Abuse (DOA) Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug of Abuse (DOA) Testing Historic Market Size by Region (2019-2024)
2.2.3 Drug of Abuse (DOA) Testing Forecasted Market Size by Region (2025-2030)
2.3 Drug of Abuse (DOA) Testing Market Dynamics
2.3.1 Drug of Abuse (DOA) Testing Industry Trends
2.3.2 Drug of Abuse (DOA) Testing Market Drivers
2.3.3 Drug of Abuse (DOA) Testing Market Challenges
2.3.4 Drug of Abuse (DOA) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug of Abuse (DOA) Testing Players by Revenue
3.1.1 Global Top Drug of Abuse (DOA) Testing Players by Revenue (2019-2024)
3.1.2 Global Drug of Abuse (DOA) Testing Revenue Market Share by Players (2019-2024)
3.2 Global Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug of Abuse (DOA) Testing Revenue
3.4 Global Drug of Abuse (DOA) Testing Market Concentration Ratio
3.4.1 Global Drug of Abuse (DOA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug of Abuse (DOA) Testing Revenue in 2023
3.5 Drug of Abuse (DOA) Testing Key Players Head office and Area Served
3.6 Key Players Drug of Abuse (DOA) Testing Product Solution and Service
3.7 Date of Enter into Drug of Abuse (DOA) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug of Abuse (DOA) Testing Breakdown Data by Type
4.1 Global Drug of Abuse (DOA) Testing Historic Market Size by Type (2019-2024)
4.2 Global Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2025-2030)
5 Drug of Abuse (DOA) Testing Breakdown Data by Application
5.1 Global Drug of Abuse (DOA) Testing Historic Market Size by Application (2019-2024)
5.2 Global Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug of Abuse (DOA) Testing Market Size (2019-2030)
6.2 North America Drug of Abuse (DOA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug of Abuse (DOA) Testing Market Size by Country (2019-2024)
6.4 North America Drug of Abuse (DOA) Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug of Abuse (DOA) Testing Market Size (2019-2030)
7.2 Europe Drug of Abuse (DOA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug of Abuse (DOA) Testing Market Size by Country (2019-2024)
7.4 Europe Drug of Abuse (DOA) Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug of Abuse (DOA) Testing Market Size (2019-2030)
8.2 Asia-Pacific Drug of Abuse (DOA) Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug of Abuse (DOA) Testing Market Size (2019-2030)
9.2 Latin America Drug of Abuse (DOA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug of Abuse (DOA) Testing Market Size by Country (2019-2024)
9.4 Latin America Drug of Abuse (DOA) Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug of Abuse (DOA) Testing Market Size (2019-2030)
10.2 Middle East & Africa Drug of Abuse (DOA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Siemens
11.1.1 Siemens Company Detail
11.1.2 Siemens Business Overview
11.1.3 Siemens Drug of Abuse (DOA) Testing Introduction
11.1.4 Siemens Revenue in Drug of Abuse (DOA) Testing Business (2019-2024)
11.1.5 Siemens Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Drug of Abuse (DOA) Testing Introduction
11.2.4 Merck Revenue in Drug of Abuse (DOA) Testing Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Drug of Abuse (DOA) Testing Introduction
11.3.4 Roche Revenue in Drug of Abuse (DOA) Testing Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Drug of Abuse (DOA) Testing Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Bio-Rad
11.5.1 Bio-Rad Company Detail
11.5.2 Bio-Rad Business Overview
11.5.3 Bio-Rad Drug of Abuse (DOA) Testing Introduction
11.5.4 Bio-Rad Revenue in Drug of Abuse (DOA) Testing Business (2019-2024)
11.5.5 Bio-Rad Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott Drug of Abuse (DOA) Testing Introduction
11.6.4 Abbott Revenue in Drug of Abuse (DOA) Testing Business (2019-2024)
11.6.5 Abbott Recent Development
11.7 Quest Diagnostics
11.7.1 Quest Diagnostics Company Detail
11.7.2 Quest Diagnostics Business Overview
11.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Introduction
11.7.4 Quest Diagnostics Revenue in Drug of Abuse (DOA) Testing Business (2019-2024)
11.7.5 Quest Diagnostics Recent Development
11.8 Psychemedics
11.8.1 Psychemedics Company Detail
11.8.2 Psychemedics Business Overview
11.8.3 Psychemedics Drug of Abuse (DOA) Testing Introduction
11.8.4 Psychemedics Revenue in Drug of Abuse (DOA) Testing Business (2019-2024)
11.8.5 Psychemedics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Drug of Abuse (DOA) Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Urine
Table 3. Key Players of Saliva
Table 4. Key Players of Hair
Table 5. Key Players of Others
Table 6. Global Drug of Abuse (DOA) Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Drug of Abuse (DOA) Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Drug of Abuse (DOA) Testing Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Drug of Abuse (DOA) Testing Market Share by Region (2019-2024)
Table 10. Global Drug of Abuse (DOA) Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Drug of Abuse (DOA) Testing Market Share by Region (2025-2030)
Table 12. Drug of Abuse (DOA) Testing Market Trends
Table 13. Drug of Abuse (DOA) Testing Market Drivers
Table 14. Drug of Abuse (DOA) Testing Market Challenges
Table 15. Drug of Abuse (DOA) Testing Market Restraints
Table 16. Global Drug of Abuse (DOA) Testing Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Drug of Abuse (DOA) Testing Market Share by Players (2019-2024)
Table 18. Global Top Drug of Abuse (DOA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug of Abuse (DOA) Testing as of 2023)
Table 19. Ranking of Global Top Drug of Abuse (DOA) Testing Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Drug of Abuse (DOA) Testing Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Drug of Abuse (DOA) Testing Product Solution and Service
Table 23. Date of Enter into Drug of Abuse (DOA) Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Drug of Abuse (DOA) Testing Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Drug of Abuse (DOA) Testing Revenue Market Share by Type (2019-2024)
Table 27. Global Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Drug of Abuse (DOA) Testing Revenue Market Share by Type (2025-2030)
Table 29. Global Drug of Abuse (DOA) Testing Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Drug of Abuse (DOA) Testing Revenue Market Share by Application (2019-2024)
Table 31. Global Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Drug of Abuse (DOA) Testing Revenue Market Share by Application (2025-2030)
Table 33. North America Drug of Abuse (DOA) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Drug of Abuse (DOA) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Drug of Abuse (DOA) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Drug of Abuse (DOA) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Drug of Abuse (DOA) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Drug of Abuse (DOA) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Drug of Abuse (DOA) Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Drug of Abuse (DOA) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Drug of Abuse (DOA) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Drug of Abuse (DOA) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Drug of Abuse (DOA) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 48. Siemens Company Detail
Table 49. Siemens Business Overview
Table 50. Siemens Drug of Abuse (DOA) Testing Product
Table 51. Siemens Revenue in Drug of Abuse (DOA) Testing Business (2019-2024) & (US$ Million)
Table 52. Siemens Recent Development
Table 53. Merck Company Detail
Table 54. Merck Business Overview
Table 55. Merck Drug of Abuse (DOA) Testing Product
Table 56. Merck Revenue in Drug of Abuse (DOA) Testing Business (2019-2024) & (US$ Million)
Table 57. Merck Recent Development
Table 58. Roche Company Detail
Table 59. Roche Business Overview
Table 60. Roche Drug of Abuse (DOA) Testing Product
Table 61. Roche Revenue in Drug of Abuse (DOA) Testing Business (2019-2024) & (US$ Million)
Table 62. Roche Recent Development
Table 63. Thermo Fisher Scientific Company Detail
Table 64. Thermo Fisher Scientific Business Overview
Table 65. Thermo Fisher Scientific Drug of Abuse (DOA) Testing Product
Table 66. Thermo Fisher Scientific Revenue in Drug of Abuse (DOA) Testing Business (2019-2024) & (US$ Million)
Table 67. Thermo Fisher Scientific Recent Development
Table 68. Bio-Rad Company Detail
Table 69. Bio-Rad Business Overview
Table 70. Bio-Rad Drug of Abuse (DOA) Testing Product
Table 71. Bio-Rad Revenue in Drug of Abuse (DOA) Testing Business (2019-2024) & (US$ Million)
Table 72. Bio-Rad Recent Development
Table 73. Abbott Company Detail
Table 74. Abbott Business Overview
Table 75. Abbott Drug of Abuse (DOA) Testing Product
Table 76. Abbott Revenue in Drug of Abuse (DOA) Testing Business (2019-2024) & (US$ Million)
Table 77. Abbott Recent Development
Table 78. Quest Diagnostics Company Detail
Table 79. Quest Diagnostics Business Overview
Table 80. Quest Diagnostics Drug of Abuse (DOA) Testing Product
Table 81. Quest Diagnostics Revenue in Drug of Abuse (DOA) Testing Business (2019-2024) & (US$ Million)
Table 82. Quest Diagnostics Recent Development
Table 83. Psychemedics Company Detail
Table 84. Psychemedics Business Overview
Table 85. Psychemedics Drug of Abuse (DOA) Testing Product
Table 86. Psychemedics Revenue in Drug of Abuse (DOA) Testing Business (2019-2024) & (US$ Million)
Table 87. Psychemedics Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug of Abuse (DOA) Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Drug of Abuse (DOA) Testing Market Share by Type: 2023 VS 2030
Figure 3. Urine Features
Figure 4. Saliva Features
Figure 5. Hair Features
Figure 6. Others Features
Figure 7. Global Drug of Abuse (DOA) Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Drug of Abuse (DOA) Testing Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Laboratories Case Studies
Figure 11. Workplace Case Studies
Figure 12. At-Home Case Studies
Figure 13. Others Case Studies
Figure 14. Drug of Abuse (DOA) Testing Report Years Considered
Figure 15. Global Drug of Abuse (DOA) Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Drug of Abuse (DOA) Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Drug of Abuse (DOA) Testing Market Share by Region: 2023 VS 2030
Figure 18. Global Drug of Abuse (DOA) Testing Market Share by Players in 2023
Figure 19. Global Top Drug of Abuse (DOA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug of Abuse (DOA) Testing as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Drug of Abuse (DOA) Testing Revenue in 2023
Figure 21. North America Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Drug of Abuse (DOA) Testing Market Share by Country (2019-2030)
Figure 23. United States Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Drug of Abuse (DOA) Testing Market Share by Country (2019-2030)
Figure 27. Germany Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Drug of Abuse (DOA) Testing Market Share by Region (2019-2030)
Figure 35. China Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Drug of Abuse (DOA) Testing Market Share by Country (2019-2030)
Figure 43. Mexico Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Drug of Abuse (DOA) Testing Market Share by Country (2019-2030)
Figure 47. Turkey Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Siemens Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2019-2024)
Figure 50. Merck Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2019-2024)
Figure 51. Roche Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2019-2024)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2019-2024)
Figure 53. Bio-Rad Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2019-2024)
Figure 54. Abbott Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2019-2024)
Figure 55. Quest Diagnostics Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2019-2024)
Figure 56. Psychemedics Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Drug of Abuse (DOA) Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Urine
Table 3. Key Players of Saliva
Table 4. Key Players of Hair
Table 5. Key Players of Others
Table 6. Global Drug of Abuse (DOA) Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Drug of Abuse (DOA) Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Drug of Abuse (DOA) Testing Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Drug of Abuse (DOA) Testing Market Share by Region (2019-2024)
Table 10. Global Drug of Abuse (DOA) Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Drug of Abuse (DOA) Testing Market Share by Region (2025-2030)
Table 12. Drug of Abuse (DOA) Testing Market Trends
Table 13. Drug of Abuse (DOA) Testing Market Drivers
Table 14. Drug of Abuse (DOA) Testing Market Challenges
Table 15. Drug of Abuse (DOA) Testing Market Restraints
Table 16. Global Drug of Abuse (DOA) Testing Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Drug of Abuse (DOA) Testing Market Share by Players (2019-2024)
Table 18. Global Top Drug of Abuse (DOA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug of Abuse (DOA) Testing as of 2023)
Table 19. Ranking of Global Top Drug of Abuse (DOA) Testing Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Drug of Abuse (DOA) Testing Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Drug of Abuse (DOA) Testing Product Solution and Service
Table 23. Date of Enter into Drug of Abuse (DOA) Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Drug of Abuse (DOA) Testing Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Drug of Abuse (DOA) Testing Revenue Market Share by Type (2019-2024)
Table 27. Global Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Drug of Abuse (DOA) Testing Revenue Market Share by Type (2025-2030)
Table 29. Global Drug of Abuse (DOA) Testing Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Drug of Abuse (DOA) Testing Revenue Market Share by Application (2019-2024)
Table 31. Global Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Drug of Abuse (DOA) Testing Revenue Market Share by Application (2025-2030)
Table 33. North America Drug of Abuse (DOA) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Drug of Abuse (DOA) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Drug of Abuse (DOA) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Drug of Abuse (DOA) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Drug of Abuse (DOA) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Drug of Abuse (DOA) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Drug of Abuse (DOA) Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Drug of Abuse (DOA) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Drug of Abuse (DOA) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Drug of Abuse (DOA) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Drug of Abuse (DOA) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 48. Siemens Company Detail
Table 49. Siemens Business Overview
Table 50. Siemens Drug of Abuse (DOA) Testing Product
Table 51. Siemens Revenue in Drug of Abuse (DOA) Testing Business (2019-2024) & (US$ Million)
Table 52. Siemens Recent Development
Table 53. Merck Company Detail
Table 54. Merck Business Overview
Table 55. Merck Drug of Abuse (DOA) Testing Product
Table 56. Merck Revenue in Drug of Abuse (DOA) Testing Business (2019-2024) & (US$ Million)
Table 57. Merck Recent Development
Table 58. Roche Company Detail
Table 59. Roche Business Overview
Table 60. Roche Drug of Abuse (DOA) Testing Product
Table 61. Roche Revenue in Drug of Abuse (DOA) Testing Business (2019-2024) & (US$ Million)
Table 62. Roche Recent Development
Table 63. Thermo Fisher Scientific Company Detail
Table 64. Thermo Fisher Scientific Business Overview
Table 65. Thermo Fisher Scientific Drug of Abuse (DOA) Testing Product
Table 66. Thermo Fisher Scientific Revenue in Drug of Abuse (DOA) Testing Business (2019-2024) & (US$ Million)
Table 67. Thermo Fisher Scientific Recent Development
Table 68. Bio-Rad Company Detail
Table 69. Bio-Rad Business Overview
Table 70. Bio-Rad Drug of Abuse (DOA) Testing Product
Table 71. Bio-Rad Revenue in Drug of Abuse (DOA) Testing Business (2019-2024) & (US$ Million)
Table 72. Bio-Rad Recent Development
Table 73. Abbott Company Detail
Table 74. Abbott Business Overview
Table 75. Abbott Drug of Abuse (DOA) Testing Product
Table 76. Abbott Revenue in Drug of Abuse (DOA) Testing Business (2019-2024) & (US$ Million)
Table 77. Abbott Recent Development
Table 78. Quest Diagnostics Company Detail
Table 79. Quest Diagnostics Business Overview
Table 80. Quest Diagnostics Drug of Abuse (DOA) Testing Product
Table 81. Quest Diagnostics Revenue in Drug of Abuse (DOA) Testing Business (2019-2024) & (US$ Million)
Table 82. Quest Diagnostics Recent Development
Table 83. Psychemedics Company Detail
Table 84. Psychemedics Business Overview
Table 85. Psychemedics Drug of Abuse (DOA) Testing Product
Table 86. Psychemedics Revenue in Drug of Abuse (DOA) Testing Business (2019-2024) & (US$ Million)
Table 87. Psychemedics Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug of Abuse (DOA) Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Drug of Abuse (DOA) Testing Market Share by Type: 2023 VS 2030
Figure 3. Urine Features
Figure 4. Saliva Features
Figure 5. Hair Features
Figure 6. Others Features
Figure 7. Global Drug of Abuse (DOA) Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Drug of Abuse (DOA) Testing Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Laboratories Case Studies
Figure 11. Workplace Case Studies
Figure 12. At-Home Case Studies
Figure 13. Others Case Studies
Figure 14. Drug of Abuse (DOA) Testing Report Years Considered
Figure 15. Global Drug of Abuse (DOA) Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Drug of Abuse (DOA) Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Drug of Abuse (DOA) Testing Market Share by Region: 2023 VS 2030
Figure 18. Global Drug of Abuse (DOA) Testing Market Share by Players in 2023
Figure 19. Global Top Drug of Abuse (DOA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug of Abuse (DOA) Testing as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Drug of Abuse (DOA) Testing Revenue in 2023
Figure 21. North America Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Drug of Abuse (DOA) Testing Market Share by Country (2019-2030)
Figure 23. United States Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Drug of Abuse (DOA) Testing Market Share by Country (2019-2030)
Figure 27. Germany Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Drug of Abuse (DOA) Testing Market Share by Region (2019-2030)
Figure 35. China Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Drug of Abuse (DOA) Testing Market Share by Country (2019-2030)
Figure 43. Mexico Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Drug of Abuse (DOA) Testing Market Share by Country (2019-2030)
Figure 47. Turkey Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Drug of Abuse (DOA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Siemens Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2019-2024)
Figure 50. Merck Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2019-2024)
Figure 51. Roche Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2019-2024)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2019-2024)
Figure 53. Bio-Rad Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2019-2024)
Figure 54. Abbott Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2019-2024)
Figure 55. Quest Diagnostics Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2019-2024)
Figure 56. Psychemedics Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232